Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWEET: Ozempic for Postpartum Dysglycemia
NCT04873050Phase 4Recruiting
- Sponsor
- Woman's
- Start
- Jan 2022
- Primary completion
- Jan 2026
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of semaglutide in prediabetes, sponsored by Woman's. Started Jan 2022; status: recruiting.
02
Drugs
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT04873050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04873050.